Diagnosing and Treating Hyperlipidemia: Recent Evidence and the Role of PCSK9-targeted Therapies

  Рет қаралды 1,455

PeerView CME

PeerView CME

Күн бұрын

Пікірлер
Lipid Management Beyond Statins: Timely Intensification With PCSK9-Targeted Therapies
48:07
Lipid Management Beyond Statins: Timely Intensification With PCSK9-Targeted Therapies
PeerView CME
Рет қаралды 542
Management of Hyperlipidemia: 2018 ACC/AHA Guideline Update
10:19
Management of Hyperlipidemia: 2018 ACC/AHA Guideline Update
Harvard Medical School Continuing Education
Рет қаралды 8 М.
Tuna 🍣 ​⁠@patrickzeinali ​⁠@ChefRush
00:48
Tuna 🍣 ​⁠@patrickzeinali ​⁠@ChefRush
albert_cancook
Рет қаралды 148 МЛН
СИНИЙ ИНЕЙ УЖЕ ВЫШЕЛ!❄️
01:01
СИНИЙ ИНЕЙ УЖЕ ВЫШЕЛ!❄️
DO$HIK
Рет қаралды 3,3 МЛН
Мен атып көрмегенмін ! | Qalam | 5 серия
25:41
Мен атып көрмегенмін ! | Qalam | 5 серия
kak budto
Рет қаралды 1,2 МЛН
乔的审判，精灵应该上天堂还是下地狱？#shorts #Fairy#fairytales
00:58
乔的审判，精灵应该上天堂还是下地狱？#shorts #Fairy#fairytales
精灵少女
Рет қаралды 9 МЛН
The ONLY Beef You Should Be Buying
21:35
The ONLY Beef You Should Be Buying
Paul Saladino MD
Рет қаралды 82 М.
Hyperlipidemia | Clinical Medicine
28:39
Hyperlipidemia | Clinical Medicine
Ninja Nerd
Рет қаралды 66 М.
Putting Basal Insulin Therapy to Work for Patients With Type 2 Diabetes Mellitus
53:02
Putting Basal Insulin Therapy to Work for Patients With Type 2 Diabetes Mellitus
PeerView CME
Рет қаралды 8 М.
Don’t Worry About “Bad” Cholesterol, Says Dr. Paul Saladino
18:57
Don’t Worry About “Bad” Cholesterol, Says Dr. Paul Saladino
The Minimalists
Рет қаралды 1,2 МЛН
Lipids Series-PCS K9 Inhibitors
17:08
Lipids Series-PCS K9 Inhibitors
Mayo Clinic
Рет қаралды 8 М.
Lp(a): What We Should Know; Need to Know; and Hope to Know - CME
53:48
Lp(a): What We Should Know; Need to Know; and Hope to Know - CME
LIPOSORBER
Рет қаралды 3,8 М.
2-9-2023 - Updates on Lipid Management: New Tools in the New Era
58:09
2-9-2023 - Updates on Lipid Management: New Tools in the New Era
WashU Medicine Department of Medicine
Рет қаралды 8 М.
The Cholesterol Wars: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Part 1)
58:08
The Cholesterol Wars: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Part 1)
Vasculearn Network
Рет қаралды 2,6 М.
Triglyceride/HDL Ratio - A Better CV Risk Predictor than LDL? (Part 1)
22:08
Triglyceride/HDL Ratio - A Better CV Risk Predictor than LDL? (Part 1)
Dr. Ford Brewer
Рет қаралды 274 М.
New Lipid Lowering Therapies A Practical Deep Dive
1:01:03
New Lipid Lowering Therapies A Practical Deep Dive
Health Innovation Yorkshire & Humber
Рет қаралды 7 М.
Tuna 🍣 ​⁠@patrickzeinali ​⁠@ChefRush
00:48
Tuna 🍣 ​⁠@patrickzeinali ​⁠@ChefRush
albert_cancook
Рет қаралды 148 МЛН